Revvity reported $7.18B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
Align Technology USD 4.23B 83.03M Jun/2026
Bio Techne USD 2.09B 74.32M Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 2.5B 46.3M Mar/2026
Celltrion KRW 434.82B 1.14B Mar/2026
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Danaher USD 52.58B 368M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 1.17B 29.29M Jun/2026
Divis Laboratories Ltd INR 167.61B 13.48B Mar/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Illumina USD 2.84B 162M Jun/2026
Intuitive Surgical USD 18.17B 693.9M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Laboratory Of America USD 8.61B 121.8M Jun/2026
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 54.77M 335K Dec/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Mettler Toledo International USD 12.82M 54.71M Jun/2026
Myriad Genetics USD 303.9M 33.5M Jun/2026
Neuren Pharmaceuticals AUD 338.45M 15.18M Dec/2025
OraSure Technologies USD 313.32M 27.5M Mar/2026
Organigram Holdings CAD 371.81M 2.36M Mar/2026
Ovoca Bio EUR 780K 485K Dec/2025
Pacific Biosciences Of California USD -33.21M 35.58M Jun/2026
Pharma Mar EUR 250.77M 1.1M Jun/2026
Qiagen NV USD 3.33B 446.45M Mar/2026
Quest Diagnostics USD 7.52B 150M Jun/2026
Quidel USD 1.85B 69.1M Mar/2026
Repligen USD 2.11B 6.57M Jun/2026
Revvity USD 7.18B 67.62M Mar/2026
Sartorius EUR 2.82B 96.3M Jun/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Tilray USD 1.58B 39.08M Sep/2025
Waters USD 15.29B 12.73B Mar/2026
Zealand Pharma A/S 14.47B 361.61M Mar/2026
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026